TITLE

Dexamethasone prevents visceral hyperalgesia but not colonic permeabilily increase induced by luminal protease-activated receptor-2 agonist in rats

AUTHOR(S)
Róka, Richard; Ait-Belgnaoui, Afifa; Salvador-Cartier, Christel; Garcia-Villar, Raphael; Fioramonti, Jean; Eutamëne, Hélëne; Bueno, Lionel
PUB. DATE
August 2007
SOURCE
Gut;Aug2007, Vol. 56 Issue 8, p1072
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Low-grade inflammation may play a role in the pathogenesis of irritable bowel syndrome (IBS). Although corticosteroids are potent inhibitors of inflammatory processes, only one study with corticosteroids in patients with postinfectious lBS exists, which suggests that prednisolone is not an effective treatment for lBS symptoms. Aim: To evaluate whether dexamethasone treatment prevents protease-activated receptor-2 (PAR-2) activation-induced visceral hyperalgesia and increased permeability in rats, and to determine whether the effects involve colonic mast cells. Methods: Abdominal contractions provoked by rectal distension were recorded in rats equipped with intramuscular electrodes. Changes in visceral hypersensitivity provoked by intracolonic administration of PAR-2-activating peptide (SLIGRL; H-serine-Ieucine-isoleucine-glycine-arginine-Ieucine-OH), changes in colonic mucosal rat mast cell protease-II (RMCP-Il) content, mast cell count and PAR-2 expression were measured after a 4-day treatment with dexamethasone (1 mg/day/rat intraperitoneally) or its vehicle (water). The effect of mast cell stabiliser (doxantrazole, 1 mg/kg intraperitoneally, 2 h before and 6 h after intracolonic infusion of SLIGRL) on SLIGRL-induced visceral hyperalgesia was also assessed. The effects of SLIGRL and a mast cell degranulator (compound 48/80) on the permeability of colonic strips from vehicle- or dexamethasone-treated rats were investigated in Ussing chambers. Results: 4 days of dexamethasone as well as doxantrazole diminished the SLIGRL-induced hyperalgesia for all volumes of distension. This effect of dexamethasone was accompanied by a reduced responsiveness of colonic permeability to compound 48/80, and decreased RMCP-II content and mast cell number. Dexamethasone treatment did not influence colonic mucosal PAR-2 expression and permeability responsiveness to SLIGRL. Conclusions: Dexamethasone treatment improves PAR-2 agonist-induced visceral hypersensitivity but does not prevent PAR-2 agonist-induced increase in colonic permeability in rats. This effect is coupled with a reduction of colonic mast cell number and RMCP-II contents.
ACCESSION #
25972135

 

Related Articles

  • Prenatal Intestinal Obstruction Affects the Myenteric Plexus and Causes Functional Bowel Impairment in Fetal Rat Experimental Model of Intestinal Atresia Khen-Dunlop, Naziha; Sarnacki, Sabine; Victor, Anais; Grosos, Celine; Menard, Sandrine; Soret, Rodolphe; Goudin, Nicolas; Pousset, Maud; Sauvat, Frederique; Revillon, Yann; Cerf-Bensussan, Nadine; Neunlist, Michel // PLoS ONE;May2013, Vol. 8 Issue 5, p1 

    Background: Intestinal atresia is a rare congenital disorder with an incidence of 3/10 000 birth. About one-third of patients have severe intestinal dysfunction after surgical repair. We examined whether prenatal gastrointestinal obstruction might effect on the myenteric plexus and account for...

  • Elevated expression of c-fos in central nervous system correlates with visceral hypersensitivity in irritable bowel syndrome (IBS): a new target for IBS treatment. Ru Zhang; Ning Zou; Ji Li; Hong Lv; Jing Wei; Xiu-Cai Fang; Jia-Ming Qian // International Journal of Colorectal Disease;Aug2011, Vol. 26 Issue 8, p1035 

    Background and aims: Although visceral hypersensitivity is a major pathophysiological feature of irritable bowel syndrome (IBS), its molecular mechanisms are still poorly understood. c-fos is a well-established marker of cell activation. Accumulating evidence demonstrates that norepinephrine...

  • The "inside scoop" on irritable bowel syndrome.  // South Asian Post;8/2/2012, p8 

    The article reports on the causes, symptoms, and preventive measures for irritable bowel syndrome (IBS).

  • Collagen Receptor Integrins: Rising to the Challenge. Zutter, M. M.; McCall-Culbreath, K. D. // Current Drug Targets;Feb2008, Vol. 9 Issue 2, p139 

    Integrins are a� heterodimeric receptors that connect the extracellular environment with intracellular signaling events. Integrins are important for normal development and function, but are also involved in the pathogenesis of diseases including cancer, autoimmunity and heart disease. We...

  • Host immune response determines visceral hyperalgesia in a rat model of post-inflammatory irritable bowel syndrome. Adam, Birgit; Tsopelas, Chris; Liebregts, Tobias; Bartholomeusz, F.; Holtmann, Gerald // Journal of Gastroenterology;Oct2013, Vol. 48 Issue 10, p1119 

    Background: Irritable bowel syndrome (IBS) is associated with visceral hyperalgesia and frequently occurs after a transient gastrointestinal infection. Only a proportion of patients with acute gastroenteritis develop post-infectious IBS suggesting differences in host response to inflammatory...

  • NewsBites.  // Tufts University Health & Nutrition Letter;Mar2001, Vol. 19 Issue 1, p2 

    Presents updates on health and nutrition in the United States as of March 2001. Physical cause of irritable bowel syndrome; Study on how to reduce gastrointestinal discomfort from jet lag and shift work; Accuracy of checking nutrition status through hair analysis.

  • Symptom Duration in Patients with Irritable Bowel Syndrome. Lembo, Tony; Fullerton, Steven; Diehl, David; Raeen, Heidi; Munakata, Julie; Naliboff, Bruce; Mayer, Emeran A. // American Journal of Gastroenterology;May1996, Vol. 91 Issue 5, p898 

    Objectives: The etiology and natural history of irritable bowel syndrome (IBS) is poorly understood. We compared rectal sensory thresholds and compliance, SCL-90 scores, and follow-up questionnaires among normal controls, patients with longstanding (>5 y) disease (L-IBS), and patients with...

  • Abordaje del paciente con diarrea crónica. Higuera-de la Tijera, María de Fátima; Alexanderson-Rosas, Elvira Graciela; Servín-Caamaño, Alfredo Israel // Medicina Interna de Mexico;nov/dic2010, Vol. 26 Issue 6, p583 

    No abstract available.

  • Haplorchis taichui as a Possible Etiologic Agent of Irritable Bowel Syndrome-Like Symptoms. Watthanakulpanich, Dorn; Waikagul, Jitra; Maipanich, Wanna; Nuamtanong, Supaporn; Sanguankiat, Surapol; Pubampen, Somchit; Praevanit, Rangson; Mongkhonmu, Srisuchat; Nawa, Yukifumi // Korean Journal of Parasitology;Sep2010, Vol. 48 Issue 3, p225 

    No abstract available.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics